Muñoz-Pérez MJ, Palafox D, Palafox J, Vichido-Luna MÁ, Espinosa-Villaseñor N, Rivas-Chávez A, Varela-Cabrera JA, Soto-Vega E

Language: Spanish
References: 13
Page: 553-557
PDF size: 553.61 Kb.

ABSTRACT

Background: COPD is a condition that affects millions of people. Standard for diagnosis of this disease is spirometry. Many young smokers at an early stage of COPD could be detected by spirometry.
Objective: To identify by means of spirometry young smokers with airflow.
Material and methods: An observational, transversal and descriptive study was made, which included men and women between 18 and 25 years old. All of them were medical students at a private university in Puebla, Mexico. Participants were divided into two groups; one of cases (smokers) and one of control (non-smokers). We applied the St. George respiratory questionnaire and took a spirometry according the ATS standards.
Results: During 11 months, 160 subjects were enrolled, 91 women and 69 men. They were divided into smokers and non-smokers groups. Smokers got a mean of 87.3 ± 9.27 in the FVC/FEV1 relation that when compared with the control group mean (91.1 ± 7.49) was statistically significant (p = 0.0045). Nineteen subjects in the group of smokers obtained mild obstruction data in the spirometry, with a FCV/FEV1 mean of 74.5 ± 4.34.
Conclusions: Identification of those subjects at risk of developing COPD at an early age would open the possibility of reducing the number of deaths associated with smoking. It is important to consider that for public health is more convenient to invest in early prevention of the groups at risk of COPD that in the treatment of this disease.

REFERENCES

1. Kuri-Morales PA, González-Roldán JF, Hoy MJ, Cortés- Ramírez M. Epidemiología del tabaquismo en México. Salud Pública Méx2006;48:S91-S98.

2. Naberan K, de la Roza C, Lamban M, Gobartt E, et al. Utilización de la espirometría en el diagnóstico y tratamiento de la EPOC en atención primaria. Arch Bronconeumol 2006;42:638-644.

3. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med 2007;28:479-513.

4. Peces-Barba G, Barbera JA, Agusti A, Casanova C y cols. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Arch Bronconeumol 2008;44:271-281.

5. Gómez G, Barrueco M, Aparicio I, Maderuelo JA, Torrecilla M. Programa de prevención del tabaquismo en alumnos de enseñanza secundaria. Arch Bronconeumol 2009;45:16-23.

6. The Global Youth Tobacco Survey Collaborative Group. Tobacco use among youth: a cross country comparison. Tobacco Control 2002;11:252-270.

7. Subsecretaría de Prevención y Promoción de la Salud, Dirección General de Epidemiología. Sistema de Vigilancia Epidemiológica de las Adicciones (SISVEA) Informe 2004. México: Dirección de Investigación Operativa Epidemiológica, Secretaría de Salud, 2004.

8. Radin A, Cote C. Primary care of the patient with chronic obstructive pulmonary disease. Part 1: frontline prevention and early diagnosis. Am J Med 2008;121:S3-12.

9. Tálamo C, Montes de Oca M, Halbert R, Pérez-Padilla R, et al. Diagnostic labeling of COPD in five Latin American cities. Chest 2007;131:60-67.

10. Buffels J, Degryse J, Heyrman J, Decramer M. Office spirometry significantly improves early detection of COPD in general practice: The DIDASCO Study. Chest 2004;125:1394-1399.

11. Shin C, Lee S, Abbott RD, Kim JH, Yeub S, Ho K. Respiratory symptoms and undiagnosed airflow obstruction in middle-aged adults: The Korean Health and Genome Study. Chest 2004;126:1234-1240.

12. Zieliñski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001;119:731-736.

13. Tam A, Morrish D, Wadswort S, Dorschied D, et al. The role of female hormones on lung function in chronic lung diseases. BMC Women’s Health 2011;11:24.